Isomab Welcomes Professor Bill Sessa as Chair of its Scientific Advisory Board#Cambridge#United_Kingdom#IsomAb#Bill_Sessa#cardiovascular_therapy
Isomab Welcomes Professor Bill Sessa as Chair of its Scientific Advisory Board
Professor Bill Sessa, former Pfizer Chief Scientific Officer, takes the lead on Isomab's Scientific Advisory Board to advance its cardiovascular therapies.
third-news.com
September 29, 2026 at 12:15 PM
Isomab Welcomes Professor Bill Sessa as Chair of its Scientific Advisory Board#Cambridge#United_Kingdom#IsomAb#Bill_Sessa#cardiovascular_therapy